Published in Nat Med on May 01, 1998
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. Retrovirology (2012) 0.96
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med (1998) 3.15
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med (1997) 3.05
Chemokine genes--beating the odds. Nat Med (1998) 0.94
Wrong kind of chemokine research. Nat Med (1997) 0.92
Replication validity of genetic association studies. Nat Genet (2001) 16.30
Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA (1998) 9.32
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N Engl J Med (1989) 6.22
Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA (2001) 5.96
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Summing up evidence: one answer is not always enough. Lancet (1998) 4.66
Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med (1996) 4.57
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA (1996) 3.88
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol (2001) 2.38
Any casualties in the clash of randomised and observational evidence? BMJ (2001) 2.37
Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35
Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA (1992) 2.32
Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ (1996) 2.29
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
Prevalence of HIV infection in the United States, 1984 to 1992. JAMA (1996) 2.15
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med (1998) 1.88
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82
Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA (2000) 1.79
Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum (2000) 1.74
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1993) 1.63
What is safe sex? Suggested standards linked to testing for human immunodeficiency virus. N Engl J Med (1987) 1.63
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA (1992) 1.62
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat (2008) 1.62
Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A (2000) 1.55
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50
Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.47
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Risk of gastrointestinal bleeding from dexamethasone in children with bacterial meningitis. Lancet (1994) 1.46
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J Acquir Immune Defic Syndr (1991) 1.45
Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA (1991) 1.44
Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med (1983) 1.41
Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol (2001) 1.40
Risk factors for postcoital bleeding among women with or at risk for infection with human immunodeficiency virus. J Infect Dis (1995) 1.40
Scintigraphic evaluation of digital circulation during the developmental and acute phases of equine laminitis. Equine Vet J (1990) 1.39
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother (2001) 1.39
Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS (1996) 1.39
Search for HIV-1 group O infection in Nigeria. Lancet (1995) 1.38
Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev (1996) 1.38
Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol (1985) 1.37
Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine (Baltimore) (2000) 1.36
Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol (1989) 1.36
Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ (1998) 1.35
Reporting of safety data from randomised trials. Lancet (1998) 1.35
Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35
Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. Clin Infect Dis (2001) 1.34
Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Int J Epidemiol (1999) 1.34
HIV infection/AIDS in the United States during the 1990s. Clin Infect Dis (1993) 1.33
Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis (1999) 1.31